Cathepsin D may help in discriminating node-negative breast cancer patients at risk for local-regional recurrence

Anticancer Research

Volumn 18, Issue 4 B, 1998, Pages 2885-2890

  Ardavanis, A ^a   Scorilas, A ^a   Loukeri, A ^a   Gerakini, F ^a   Pissakas, G ^a   Missitzis, I ^a   Apostolikas, N ^a   Yiotis, I ^a  

^a SAINT SAVVAS HOSPITAL   (Greece)

Author keywords

Cathepsin D; Loco regional recurrence; Node negative breast cancer

Indexed keywords

CATHEPSIN D; TUMOR MARKER;

ADULT; ARTICLE; BREAST CANCER; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS;

ADULT; BREAST NEOPLASMS; CATHEPSIN D; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 0031842864     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Liotta AL, Stetler-Stevenson WG: Principles of Molecular cell Biology: Cancer Metastasis. In: Cancer. Principles and Practice of Oncology, p 141, VT De Vita, S Helman. SA Rosenberg eds, Lippincott, 1993.
2. Westley B, Rochefort H: A secreted glycoprotein induced by estrogen in human breas cancer cell lines. Cell 20: 353, 1980.
3. Spyratos F, Maudelonde T, Brouillet JP, Brunet M, Defrenne A, Andrieu C, Hacenek K, Desplaces A, Ronesse J, Rochefort H: Cathepsin-D: An independent prognostic factor fa metastasis of breast cancer. Lancet 8672 (11): 1115-8, 1989.
4. Thorpe SM, Rochefort H, Garcia M, Freiss G, Christensen IbJ, Rose C: Association between high concentrations of Mr 52000 cathepsin-D and poor prognosis in primary human breast cancer. Cancer Res 49: 6008-14, 1989.
5. Tandon A, Clark G, Chamness GC, Chirgwin J, Mc Guire W: Cathepsin-D and prognosis breast cancer. NEJM, 322: 297-302,1990.
6. Scorilas A, Yiotis J, Gouriotis D, Keramopoulos A, Ampela K, Trangas T, Talieri M: Cathepsin-D and c-erb-B 2 have an additive prognostic value for breast cancer patients. Anticancer Res 13: 1895-900, 1993.
7. Spyratos F, Martin PM, Hacene K et al: Multiparametric prognostic evaluation of biological factors in primary breast cancer. J Natl Cancer Inst 84: 1266,1993.
8. Ravdin PM: Evaluation of cathepsin D as a prognostic factor in breast cancer. Breast Cancer Res Treat 24: 219, 1993.
9. Janicke F, Schmitt M, Van Putten WLJ, et al: Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer. Breast Cancer Res Treat 24: 195, 1993.
10. Bouchet C, Spyratos F, Martin PM, et al: Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast cancer. Br J Cancer 69: 398, 1994.
11. Duffy MJ, Reilly D, Mc Dermott E, et al: Urokinase plasminogen activator as a prognostic markerin different subgroups of patients with breast cancer. Cancer 74: 2276, 1993.
12. Remmele W, Sauer-Manthey J: Comparative biochemical and immunohistochemical studies on the cathepsin D content of human breast cancer. Virchows Arch A Pathol Anat Histopathol 422-67, 1993.
13. Armas OA, Gerald WL, Lesser ML, et al: Immunohistochemical detection of cathepsin D in T2NOM0 breast carcinoma: An immunohistochemical study. Am J Surg Pathol 18: 158, 1994.
14. Ravdin PM, Tandon AK, Allred DC, et al: Cathepsin D by Westem blotting and immunohistichemistry: failure to confirm correlations with prognosis in node-negative breast cancer. J Clin Oncol 12: 467, 1994.
15. Johnson MD, Torri JA, Lippman ME, et al: The role of cathepsin D in the invasiveness of human breast cancer cells. Cancer Res 52: 6101, 1992.
16. Tetu B, Brisson J, Cote C, et al: Prognostic significance of cathepsin D expression in node-positive breast carcinoma: an immunohistochemical study. Int J Cancer 55: 1429, 1993.
17. Henry JA, Mc Carthy AL, Argus B et al: Prognostic significance of the estrogen-regulated protein cathepsin D in breast cancer: An immunohistochemical study. Cancer 65: 265-71, 1990.
18. Gion M, Mione R, Dittadi R et al: Relationship betweeen cathepsin D and other pathological and biological parameters in 1752 patients with primary breast cancer. Eur J Cancer, 31A(5): 671-7, 1995.
19. Ardavanis A, Scorilas A, Amanatidou A, Gerakini F et al: Cathepsin D concentration in tumor cytosols improves the accuracy of prognostic evaluation of primary breast cancer. Anticancer Res 17(2B): 1405, 1997.
20. Clark GM: Prognostic and predictive factors. In: Diseases of the Breast, Harris JR, Lippman ME, Morrow M, Hellman S Eds, Lippincott-Raven Publ, Philadelphia, 1996.
21. Aaltonen M, Lipponen P, Kosma VM: Prognostic value of cathepsin D expression in female breast cancer. Anticancer Res 15(3): 1033-7, 1995.
22. Joensuu H, Toikkanen S, Isola J: Stromal cell cathepsin D expression and long-term survival in breast cancer. Br J Cancer 71(1): 155-9, 1995.
23. Hawkins RA, Tesdale AL, Killen ME et al: Prospective evaluation of prognostic factors in operable breast cancer. Br J Cancer 74 (9): 1469-78, 1996.
24. Hughes KS, Lee AK, Rolfs A: Controversies in the treatment of ductal carcinoma in situ. Surg Clin North Am, Apr; 76(2): 243-65, 1996.
25. Emmert-Buck MR: Cathepsin D and prognosis in breast cancer: one piece of a larger puzzle? Editorial; comment. Hum Pathol 27(9): 869-71, 1996.